Figure 2.
![FDG-PET imaging of MALT lymphomas and other systemic manifestations in pSS. (A–C) pSS patient with parotid gland MALT lymphoma (biopsy side: right parotid gland) and pulmonary nodules on PET MIP image (A) and fused PET/CT images (B, C). (D, E) pSS patient with a lacrimal gland MALT lymphoma (left lacrimal gland). (F–I) Systemic manifestations of pSS found by FDG-PET/CT imaging. (F) PMR, with FDG uptake in shoulder and hip regions. (G) Intense FDG uptake in lymph node regions (head/neck, axillary and inguinal), histology axillary lymph node: no signs of lymphoma. (H) Enthesopathy hip region. (I) Arthritis right SI joint. FDG: [18F]-fluorodeoxyglucose; pSS: primary SS; MALT: Mucosa Associated Lymphoid Tissue](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/rheumatology/62/10/10.1093_rheumatology_kead071/1/kead071f2.jpeg?Expires=1749315242&Signature=BheAtlgNz5pY2kJR8NfTGJXwIU9iqyFg9jKGbviKTJ8H4OaIjKFhJlHQ40oCLGGNsaVqGgAbwbWlzV1nrHJo3HPtc6QLqinpuJGMNC6dBk8myXdDNgWPWmKwUYKbUTMSAPAi1cPT~hkgTnCvOabua0IsjJFmY5-l9osDPS0E~AnZI6TP-W7wbBL8dSLcDJXQ6FF4GEdPZukjE9YjvTRX4Y3On9D0R1dw4l2rdP2tA7Iljmxh-ZkQ4KMzkNfkV6ESVnRIfpckdFmbfwE-L9CCj~xYVQyoKXjTtzekkrMZQk52kkp3JHOvd62TsmumeIawqEvjYyCGG9oBukXLJ0jX1w__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
FDG-PET imaging of MALT lymphomas and other systemic manifestations in pSS. (A–C) pSS patient with parotid gland MALT lymphoma (biopsy side: right parotid gland) and pulmonary nodules on PET MIP image (A) and fused PET/CT images (B, C). (D, E) pSS patient with a lacrimal gland MALT lymphoma (left lacrimal gland). (F–I) Systemic manifestations of pSS found by FDG-PET/CT imaging. (F) PMR, with FDG uptake in shoulder and hip regions. (G) Intense FDG uptake in lymph node regions (head/neck, axillary and inguinal), histology axillary lymph node: no signs of lymphoma. (H) Enthesopathy hip region. (I) Arthritis right SI joint. FDG: [18F]-fluorodeoxyglucose; pSS: primary SS; MALT: Mucosa Associated Lymphoid Tissue
